|
Interagency Midazolam Product Coordination Team
|
Committee, Work group, Advisory group, or Task Force
|
FDA, OS
|
NINDS
|
A collaboration led by the Department of Health and Human Services (HHS) to facilitate activities, both research and regulatory, related to the Food and Drug Administration (FDA) approval of midazolam for use in treating nerve agent exposure.
|
|
Interagency Modeling and Analysis Group (IMAG)
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NIBIB, CSR, FIC, NCATS, NCI, NHGRI, NHLBI, NIA, NIAID, NIAMS, NICHD, NIDA, NIDCD, NIDDK, NIEHS, NIGMS, NIMH, NINDS, NLM, OD/DPCPSI/OBSSR
|
The Interagency Modeling and Analysis Group (IMAG) is comprised of program directors from ten government agencies in the U.S. and Canada, including the National Institutes of Health (NIH), the National Science Foundation (NSF), Department of Energy (DOE), Department of Defense (DOD), the United States Department of Agriculture (USDA), the Canadian federal research network for Mathematics of Information Technology and Complex Systems (MITACS), the National Aeronautics and Space Administration (NASA), the United States Department of Veterans Administration (USDVA), the Food and Drug Administration (FDA), and the Intelligence Advanced Research Projects Activity (IARPA). The purpose of IMAG is to bring together program officers who have a shared interest in supporting modeling and analysis methods in biomedical, biological and behavioral systems. IMAG has promoted and supported a wide variety of modeling over the past 10 years, notably the multi-scale modeling (MSM) initiative, which was originally a multi-agency funding opportunity announcement and continued on by different IMAG agencies through separate funding opportunity announcements. The MSM Consortium Meeting scheduled for 2013 was cancelled due to the government shutdown, but was held in September 2014.
|
|
Interagency Pain Research Coordinating Committee (IPRCC)
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, FDA, IHS, SAMHSA
|
NINDS, NCCAM, NIDA, NIDCR, NINR
|
The Interagency Pain Research Coordination Committee is an Affordable Care Act mandated committee to coordinate pain research activities across the government.
|
|
Interagency Select Agent Review Group (ISARG)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, OS
|
OD/OSP, NIAID, OD/OM/OB
|
The ISARG reviews foreign institutions for comparable select agent requirements (42 CFR Part 73) for registration, security risk assessments, safety plans, security plans, emergency response plans, training, transfers, record keeping, laboratory inspections, and notification. In addition, the ISARG provides recommendations to the National Institute of Allergy and Infectious Diseases (NIAID) about restrictions on awards for research involving select agents taking place in foreign institutions.
|
|
Interagency Select Agent Review Group (ISARG)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA
|
NIAID
|
The Interagency Select Agent Review Group (ISARG), composed of members from the Food and Drug Administration (FDA), the Centers for Disease Control and Prevention (CDC), the Department of Justice, and the Department of State, advises the National Institute of Allergy and Infectious Diseases (NIAID) on whether facilities and procedures at NIAID-funded foreign research sites are comparable to those required by the Select Agent Regulations for domestic institutions before Select Agent work at the foreign site may proceed.
|
|
Interagency Subcommittee on Education (ISED) of the Interagency Committee on Disability Research (ICDR)
|
Committee, Work group, Advisory group, or Task Force
|
ACF, AHRQ, CDC, HRSA
|
NICHD
|
The Interagency Committee on Disability Research (ICDR) is mandated to promote interagency coordination, collaboration, and communication. It must identify, assess, and seek to coordinate all Federal programs, activities, and projects, and plans for such programs, activities, and projects with respect to the conduct of research (including assistive technology research and research that incorporates the principles of universal design) related to rehabilitation of individuals with disabilities. The committee facilitates the effective exchange of information on disability and rehabilitation research activities among its member agencies. We coordinate activities that span the areas of assistive technology and universal design; medical rehabilitation; data and statistics; employment; health disparities, and education. The Interagency Subcommittee on Education (ISED), a subcommittee of ICDR, focuses on issues related to the education of persons with disabilities by collecting input from stakeholders to inform planning; identifying emerging research areas; assessing research gaps, synergies and duplications; and making recommendations to inform the federal research agenda.
|
|
Interagency Subcommittee on Medical Rehabilitation (ISMR)
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC
|
NICHD, NCATS, NCI, NEI, NHLBI, NIAMS, NIBIB, NIDA, NIDCD, NIMH, NINDS
|
The Interagency Subcommittee on Medical Rehabilitation (ISMR) is composed of representatives from Federal agencies involved in disability and related research, including rehabilitation research. After receiving input from targeted individuals, the Committee shall identify, assess, and seek to coordinate all Federal programs, activities, projects, and plans for such programs, activities, and projects with respect to the conduct of research (including assistive technology research and research that incorporates the principles of universal design) related to rehabilitation of individuals with disabilities.
|
|
Interagency Task Force on Antimicrobial Resistance (ITFAR)
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, CMS, FDA, HRSA, OS
|
NIAID
|
The Interagency Task Force on Antimicrobial Resistance (ITFAR) is a coordinating committee within the U.S. government for research on antimicrobial resistance.
|
|
Interagency Task Force on the Arts and Human Development
|
Committee, Work group, Advisory group, or Task Force
|
ACF, ACL, SAMHSA
|
OD/DPCPSI/OBSSR, NCCAM, NIA, NICHD, NIMH
|
Integrate national support for research into the arts'' role to improve human health and wellbeing over the lifecourse. Please note, this project also conducts webinars and discusses potential research. This activity also involves resource development and provides public webinars, and discussion of potential/future joint agency FOAs.
|
|
Interagency Workgroup on Technology to Facilitate Aging in Place
|
Committee, Work group, Advisory group, or Task Force
|
ACL, CMS, FDA
|
NIA, NCI, NHLBI, NIBIB, NINDS, NINR
|
The purpose of this Trans-NIH/Inter-Agency group is to develop new platforms for everyday life technology that will enhance the common goals of multiple NIH institutes and other federal government agencies by improving the capability to rapidly conduct peer-reviewed technology research to facilitate aging in place, with a special emphasis on people from underrepresented groups. A platform is a group of technologies that are used as a base upon which other applications, processes or technologies are developed. This initiative grew out of the Senior Independent Living Research (SILvR) Network Initiative - See more at: http://silvrnetwork.org/ .
|